Good day everyone, and welcome to the Entegris third quarter 2016 earnings call. Today's call is being recorded. At this time, for opening remarks and introductions, I would like to turn the call over to Steve Cantor, Vice President of Corporate Relations. Please go ahead, sir.
Great. Thank you. Thank you all for joining our call this morning. Earlier, we announced the financial results for our third quarter ended October 1st, 2016. You can access a copy of our press release on our website, entegris.com. Before we begin, I'd like to remind listeners that our comments today will include some forward-looking statements. These statements involve a number of risks and uncertainties, which are outlined in detail in our reports and filings with the SEC. On this call, we will also refer to non-GAAP financial measures as defined by the SEC in Regulation G, and you can find a reconciliation table on our website. On the call today are Bertrand Loy, President and CEO, and Greg Graves, CFO. Bertrand will now begin the call. Bertrand?
Thank you, Steve. I will make some general comments. Greg will provide more details on our financial results and our Q4 guidance. We'll open the line for questions. I am pleased with the third quarter results, which put us squarely on track to achieve a record year for Entegris in both sales and profits. Year to date, we have grown 6% organically, a performance that we believe exceeds our markets and the growth rates of most other electronic materials companies. Our ability to outpace our markets provides evidence of the soundness of our strategies, the success of our customer engagement model, and the quality of our execution. For the third quarter, I want to specifically highlight a number of accomplishments. We delivered solid top and bottom-line results. We generated record free cash flow. We continued to pay down our debt.
Finally, I want to recognize our global manufacturing teams for achieving best-in-class levels of quality. Our third quarter results benefited from relatively favorable trends in our markets. Wafer fab activity was better than expected relative to the seasonal softening we had anticipated. End market demand for smartphones and 3D NAND devices remained strong. We also capitalized on the initial efforts by some of our customers to ramp the 10 nanometer nodes. Our liquid filtration business once again performed at record levels as we continue to capture new filtration opportunities and grow our share. The i2M facility is now fully commissioned, and we are ideally positioned to address the increased cleanliness requirements for bulk photoresist manufacturing. A number of our other product platforms reported strong performance in Q3.
Continued high levels of new fab construction and retrofit activity, as well as new investments in 10 nanometer technology, helped drive continued strength in our fluid handling and microenvironment businesses. Sales of our formulated cleans in Q3 reflected the high level of fab activity and were in line with our expectations with good demand for our post-CMP cleaning chemistries. In addition, our advanced deposition business performed at near record levels, driven by adoption of new materials used in advanced CVD processes. Turning to our specialty gas product lines, strong sales of gas filters and diffusers were offset by weaker sales of some of our specialty gas solutions, which were impacted by the timing of fab customer demand.
One of the outcomes of our customer engagement model and our many customer collaborations is the clear indication of the criticality of our solutions in addressing the industry's emerging process challenges across the electronics ecosystem. Our ability to leverage materials knowledge, combined with our clean and safe materials handling solutions and our contamination control expertise, is resulting in unique yield-enabling solutions, not only for logic, but increasingly for advanced memory devices. During our Analyst Day in July, we spoke about five of our top growth initiatives that demonstrate the breadth of our capabilities across all major fab processes, including lithography, implant, etch, deposition, and CMP. These projects expand our TAM and address new applications that we have not previously served.
I mentioned the bulk photoresist filtration opportunity earlier, all five of these initiatives are progressing well and are on track to generate, in total, $70 million of incremental revenue by 2018. I am also pleased with our operational execution, which is another very important component of our value proposition. Over the past several years, through continuous investment and relentless focus, we have improved our quality from about 3.5 sigma to levels exceeding five sigma. Given that we manufacture 15,000 SKUs across a number of manufacturing sites in the world, this is no small feat. As pleased as I am about how far we've come, we are continuing to drive to even higher levels of excellence in our quality systems, in our technology and in everything we do. 2016 is the 50th anniversary of Entegris.
We expect it to be a year of many records for us and to be the precursor of many more successful years. That optimism is based on our unique position in what is a growing and dynamic market. It is also based on our demonstrated ability to be viewed by our customers as their partner of choice, by virtue of the quality of our execution, our unique value proposition, and the role we play across the entire semiconductor and microelectronics ecosystem. I will now turn the call to Greg for the financial detail.
Thank you, Bertrand. I am pleased with the results of the quarter. Our sales were at the high end of our guidance. We delivered solid net income and EPS and record cash flow. On a year-to-date basis, sales were up 6% above last year. Non-GAAP EPS was up $0.07 or 11% over last year, excluding the impact of a $0.03 unusual currency gain we highlighted in Q3 of last year. Third quarter sales of $297 million declined modestly from Q2, reflecting normal seasonality. Sales were up 10% from a year ago. Foreign exchange was a 1% sequential tailwind in the quarter. It positively impacted revenues 2.5% on a year-over-year basis.
The operating results included an impairment charge of $5.8 million, related primarily to certain 450-millimeter production assets. Severance charges of $2.4 million related to a realignment of our organization to drive greater customer focus and internal functional alignment. By segment, sales for Critical Material Handling, or CMH, declined 1% to $193 million from Q2. The non-GAAP operating margin for CMH of 27.4% in Q3 was essentially flat with 27% in Q2. Sales for Electronic Materials, or EM, of $104 million was 4% lower than $108 million in Q2. EM's non-GAAP operating margin of 20.4% declined from 25.4% in Q2. For both CMH and EM, the non-GAAP results exclude the impairment and severance charges previously mentioned. Third quarter non-GAAP gross margin was 43.6%, which was below normalized levels.
The lower margin was the result of lower factory utilization in one of our high-margin products. It coincided with a modestly unfavorable product mix, higher scrap rates, and greater than expected spending on a number of one-time procurement and quality initiatives. We expect gross margin to be flat to up modestly in Q4 in spite of expected seasonally lower revenue levels. We controlled our expenses well in the quarter. Excluding amortization of $11 million, the previously mentioned severance charges, non-GAAP operating expenses in Q3 were $75.4 million. We expect non-GAAP operating expenses to be $74 million-$76 million in the fourth quarter. Adjusted operating margin was 18.2%. Net interest expense was $9.3 million in Q3, consistent with the past several quarters. Our GAAP tax rate for the quarter was 15%. Our non-GAAP rate was 23%. The tax rate reflected a favorable geographic income mix.
Our non-GAAP earnings per share was $0.24, in line with our expectations. Adjusted EBITDA for the quarter was $67.7 million, giving us an EBITDA margin of almost 23%. Cash flow from operations for the quarter was $72 million. Free cash flow was a record high $59 million. The excellent cash flow was driven by good working capital management and lower capital spending. Accounts receivable declined by $13 million. DSOs improved to 52 days in Q3 compared to 54 days in Q2. Inventories increased by $5 million sequentially. Inventory turns of 3.6 were consistent with Q2. Third quarter CapEx was $13.1 million. Year-to-date CapEx was $45 million. We are now expecting full-year CapEx of approximately $60 million-$65 million. We grew our cash balance to $412 million, of which $172 million was in the U.S.
Total long-term debt, including current maturities, was $608 million as we continue to de-lever the balance sheet. We repaid $25 million in Q3 and expect to repay an additional $100 million over the next 12 months. Our net leverage ratio is less than 0.8 times, which is consistent with what we expected at the time of the ATMI acquisition. We are continuing to execute our capital allocation strategy, which balances debt repayment, building liquidity for potential M&A, and opportunistic share repurchases. Turning to our outlook for Q4, we expect sales to range from $275 million-$290 million, reflecting current demand trends. The fourth quarter is typically seasonally down from the third quarter. At these revenue levels, we expect non-GAAP EPS to be $0.19-$0.23 per share, consistent with our target model.
In summary, we performed well in the quarter and are on pace to achieve a record year and to outpace the industry. We generated record cash flow. Finally, we are excited about our new product pipeline and our strategic initiatives that position us to outperform our markets in 2017 and beyond. Operator, we'll now take questions. Operator?
Thank you. If you would like to ask a question, please signal by pressing star one on your telephone keypad. If you're using a speakerphone, please make sure your mute function is turned off to allow your signal to reach our equipment. Again, press star one to ask a question. We'll pause for just one moment to allow everyone the opportunity to ask a question. Again, that is star one. We will take our first question from Weston Twigg of Pacific Crest Securities. Please go ahead.
Pretty substantial drop in Q3. You mentioned some wafer scrap, or not wafer, sorry, not wafer scrap. You mentioned some material scrap and mix. I'm wondering, can you give us a little bit more color on what the scrap was related to? Is that part of the drive for quality, should we expect more moving forward? With respect to the mix, just wondering if you've kind of worked through all the startup issues in the i2M facility and if that had any relation to the lower GM.
Okay. Really two parts to your question, Wes. First of all, with regard to the gross margin in Q3, overall, by business unit, our margins were excellent. We had one area where we had weakness in our gross margin due to lower volumes and lower manufacturing volumes, and that was really in our Arsine and Phosphine product lines. We don't expect that to recur in the next quarter. The scrap issue related to the same thing. It was a number of products that just did not meet our quality standards, we ultimately scrapped them out. As we move into Q4, we'd expect those issues to be behind us. We expect higher volumes in those gas-related businesses and would expect our margins to be flat to up modestly, in spite of the fact that our volumes will be down a little bit.
The second part of the question related to the i2M center, I'm happy to say that that transition is completely behind us. I will say we spent a little bit more money in Q3 than we anticipated, but overall, our liquid filtration margins, which that business is part of, were very strong. We're completely out of the Millipore facility, those recurring costs will be gone in Q4. Overall, when I think about the margins, moving into Q4, I feel pretty good. Just to put it a little bit in context, if you were to look at our margins over the last eight quarters, we've got a quarter where they were 41% and a quarter where they were 46%, but mostly they run in that 44%, 45% range.
While this margin was a little bit weaker than we would've liked, it certainly wasn't alarming to us or sort of out of the range of reason.
Okay, that's helpful. Just as a follow-up, I think last quarter you mentioned that some of your trailing edge customers have started buying some more of your leading-edge products, particularly the filtration. I was just wondering if that trend is still accelerating, or is that more of a one-time increase related to new product availability?
Wes, I think this is a trend that I hope will be continuing in the future. We have, as I mentioned before, invested a lot in increasing the level of coverage and the level of support to the trailing edge fabs, and they are constantly evaluating a number of new solutions. Filtration solutions, but also other products and materials, and we hope that we're going to continue to capitalize on those new engagement levels. This is a part of our business that has done well year to date, and I would expect that to continue to be a source of strength in our top line going forward.
All right. Thank you very much.
We will take our next question from Patrick Ho of Stifel. Please go ahead.
Thank you very much. Bertrand, first, in terms of some of the growth initiatives you've talked about, in terms of the different markets, what's been the biggest surprise on the upside surprise for you? Has 3D NAND helped on the deposition side of things? Where have you seen probably the fastest growth among those five market opportunities you highlighted at your Analyst Day?
Patrick, if you recall during the Analyst Day, we classified those five opportunities in, I would say, three buckets. The first two, the bulk photoresist filtration solutions and the new families of boron mixtures, are products that are launched and will have an immediate impact to the top line. That was the expectation. This is, in fact, what we have been experiencing since the beginning of the year. Those two products have been meaningfully contributing to our growth trajectory since the beginning of the year. The other products are still in the early stages of development and evaluation by our customers. The progress for our new family of coatings, the new deposition materials continue to be very exciting. A lot of really good positive feedback, but still very early stage and fairly limited impact on our top line so far this year.
The last is really something of a slightly different nature, and that's really putting together the knowledge that we have of the CMP process, combine that with the silicon carbide and coating technology knowledge that we have in developing a pad conditioner. This is a fairly small team, but the results are very promising. We've been primarily engaging with logic customers so far this year. A lot of success there. I think the team will start engaging with memory makers in the very near future. Next on the horizon will be the trailing edge fabs. As you know, the value proposition for that product is around increasing the life of the pad conditioners and the life of the pad themselves by a factor of 2x. In doing so, we significantly contribute to improving the cost of ownership of our customers.
We would expect that those products would be very relevant, not just for leading edge, but also for trailing edge.
Great. That's helpful. Maybe as a follow-up to the details you just provided there, is it fair to assume that some of these new opportunities, like you mentioned on the deposition materials that you mentioned, they'll start contributing to revenues in 2017?
That would be my expectation. Again, I think, the development of those new class of precursors really ties to the new complexity of the device architecture as the industry continues their efforts to scale up vertically. What we're trying to do here is not only to develop the material itself, but really to come up with a material that is purer than anything that exists in the market today, and to develop an integrated solution, including a delivery system that leverages our fluid handling knowledge, our coating capabilities, our in-line monitoring technology, as well as our knowledge of gas contamination control. This is really what we're after, is really this system solution for our OEM and fab customers. Again, feedback from the market has been extremely promising.
To your point, I don't expect this particular technology and this particular platform to have any meaningful impact on our top line until later in 2017 and early 2018.
All right. Final question for me, maybe for Greg, in terms of the financials, as well as the way you've been able to generate cash and your balance sheet management. As you get some of these new products to the marketplace, how are you managing, I guess, the supply chain to maintain the high turns you've been able to deliver as well as this cash flow generation?
I think you're talking specifically about inventory. Maintaining inventory at current levels and current turns and even looking for some modest improvement over time is one of our core corporate objectives. I think it's front and center with everyone in the supply chain. I would expect you'll continue to see inventory turns in the ranges we're at now or, like I said, slightly better. Overall, though, I would say I'm very pleased with our cash generation. I'm really pleased with the amount of cash we've been able to drive back to the U.S. I think we'll continue to repatriate cash over the next year. We've got excellent liquidity in the U.S. to reduce the debt and still have firepower for M&A.
Great. Thank you.
We will take our next question from Dick Ryan of Dougherty. Please go ahead.
Thank you. Greg, in your fourth quarter guidance, can you give us a sense of what you're thinking about for both the unit and the CapEx side of the businesses?
I think that we're guiding down slightly and that guidance, I think that would be equal on both sides of the business.
Yeah, I can help with that question. Just say this, again, right now we are still experiencing very healthy levels of bookings in our business entering the quarter. We expect the normal seasonality to set in, and the fab activity to slow down in the back end of the fourth quarter. As Greg mentioned, we continue to expect some very healthy industry conditions in line with seasonal pattern. To put that in perspective, the midpoint of our Q4 guidance Represent an increase of 6% versus the same quarter of last year. I think that we're going to finish the year on a very strong note.
Okay, great. Could you give us a sense of what CapEx might look like for 2017 versus 2016?
Very preliminarily, I would expect it to be in the $80 million-$90 million range next year. We came into this year talking about an $80 million number. We had a number of projects, because of customer ramps, a number of projects where we delayed putting capacity into place, those will end up happening next year.
Okay. I think you review your
I was just going to say, we'll put a finer point on that coming out of Q4.
Sure. I think you review your capital allocation strategies in the fall, great success to date, another $100 million over the next year in debt paydown expectations. How do you handicap that? This debt paydown was, or it seemed to be, the top priority. How do you handicap that with M&A opportunities or stock buyback now?
I think you're correct. I think short term, our preference will be to pay down the debt. We continue to believe that M&A is our preferred capital allocation option. As we've reviewed with you, we believe that the ATMI acquisition was a great success that did allow us to create significant value for all stakeholders. Frankly, that has given us confidence and hopefully credibility among the investment community that we can be an effective consolidator in our space. The other thing that we learned with the ATMI acquisition is that we need to be disciplined, and what it means for us is that we're going to be thoughtful and potentially patient before we act. I would argue that right now, again, the focus and the priority remains organic growth.
We have many very exciting opportunities right in front of us, and we need to execute flawlessly. In that context, as Greg mentioned, our preference would be to pay down the debt, delever the balance sheet, regain flexibility without compromising our dry powder. When the time is right, you should expect us to acquire some high-quality businesses at the right price.
Great. Thank you.
We will take our next question from Amanda Scarnati of Citi. Please go ahead.
Thanks for taking the question. Just kind of continuing on that M&A question, what is the size of the acquisition that you would be considering down the road? Would it be another transformative acquisition the relative size of ATMI, or would it be something smaller, like a $50 million specialty chemical company?
Amanda, again, as you would expect, we are working on, like any other company that wants to be an effective M&A player. We are building up a pipeline of potential M&A targets. In that pipeline, as you would expect, you would see companies of many different sizes. The question would be one of actionability and affordability. We will continue to test all of that, and when the time is right, we will share more with you.
Greg, what is the percentage of cash that's currently onshore versus offshore?
There's $172 million onshore out of the $412 million.
Okay.
A little bit less than half.
The last question I have is just with operating margins. Are there any levers that could be used to improve operating margins into the 20% range? Or is this kind of mid-teen range the more appropriate run rate to be in for operating margin?
No. Our target model at $300 million-plus is to have operating margins of 20%, and I think we're well positioned to deliver on that.
All right. Thank you.
In fact, if you look back at last quarter, we were right at 20%, excluding some of the one-time items.
Once again, if you would like to ask a question, please signal by pressing star one on your telephone keypad. Again, that is star one to ask a question. We will take our next question from Tom Diffley of D.A. Davidson. Please go ahead.
Yeah, good morning. I guess I have a longer-term question here on the margin front. If you do get the $70-plus million of incremental revenue from these five new product lines, what is the impact to margins on a go-forward basis? Similarly, what would the impact be if you got a substantial amount of growth from IoT at the trailing edge?
From a gross margin perspective, our new products do have higher margins. When you think about the IoT, the gross margins on those businesses would be lower, but the operating margin would be in line with corporate operating margin because some of those products, over time, we've experienced modest ASP erosion, but we're not spending much in terms of R&D, because IoT is primarily legacy products. Lower gross, but consistent operating margins. When you think about the margin long term, I've consistently said, think about this business as kind of a mid-40s operating margin. It'd be great to say that I think we'll get to 47 or 48, but I don't really see that. I think at the end of the day, the customers are going to allow us to have something in the mid-40s.
Okay. You mentioned that the newer products are higher gross margin. Are they also higher operating margin, or is there a level of R&D in there that keeps them in check?
I would say across the portfolio, the operating margins are, legacy versus new, I'd say relatively consistent on an operating margin perspective.
Okay, that's helpful. When you look at some of the write-offs, do you have any active 450 millimeter programs left, or are they, at this point, all shut down?
No, right now, this entire initiative is really on ice. It's pretty clear that the industry will not be transitioning to 450 millimeter wafer anytime soon. As a result, that's what really led us to decide to record this impairment charge in Q3. Having said that, we continue to view the transition to larger wafer as a potential growth opportunity for Entegris if and when the industry decides to migrate to 450. Again, if and when that happens, we'll be ready to re-engage. At this point in time, there is really no development effort within the company.
Okay, good to know. Finally, you talked a lot about the cash. What is the cost of repatriating your cash at this point?
We've probably got another $100 million or so that we can repatriate on a highly efficient basis. We'll bring back about half of that $100 in the next six months and the remainder over the next six to 18 months. That, like I said, it won't be zero, but it'll be very close to zero. Beyond that, it would be the delta between the rate where the cash was earned and the U.S. rate.
Okay. When you look at the generation of cash going forward, what % do you think will be generated onshore versus offshore?
We're generating approximately 40% of our free cash flow in the U.S.
Okay, great. Thanks for your time this morning.
There are no further questions at this time. I will now turn the call over to Steve Cantor for additional comments and closing remarks.
Great. Before closing, I do want to note that we will be in New York for investor meetings tomorrow, and we will be participating in the Morgan Stanley Global Chemicals Conference in November. If you want more information about those activities, you can contact me. We look forward to updating you on our next quarterly call. Thank you and have a great day.
That concludes today's conference. Thank you for your participation. You may now disconnect.